Cite
Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition).
MLA
Hong, Bu, et al. “Consensus on Clinical Diagnosis and Medical Treatment of HER2-Low Breast Cancer (2022 Edition).” Journal of the National Cancer Center, vol. 3, no. 4, Sept. 2023, pp. 266–72. EBSCOhost, https://doi.org/10.1016/j.jncc.2023.09.002.
APA
Hong, B., Ying, F., Zhaoqing, F., Xichun, H., Man, L., Qiao, L., Ning, L., Ting, L., Jianyun, N., Yueyin, P., Xiaowei, Q., Zhimin, S., Guohong, S., Tao, S., Yue-E, T., Zhongsheng, T., Jiayu, W., Shusen, W., Xue, W., … Jiuda, Z. (2023). Consensus on clinical diagnosis and medical treatment of HER2-low breast cancer (2022 edition). Journal of the National Cancer Center, 3(4), 266–272. https://doi.org/10.1016/j.jncc.2023.09.002
Chicago
Hong, Bu, Fan Ying, Fan Zhaoqing, Hu Xichun, Li Man, Li Qiao, Liao Ning, et al. 2023. “Consensus on Clinical Diagnosis and Medical Treatment of HER2-Low Breast Cancer (2022 Edition).” Journal of the National Cancer Center 3 (4): 266–72. doi:10.1016/j.jncc.2023.09.002.